Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point

Real-world drug repurposing—the immediate “off-label” prescribing of drugs to address urgent clinical needs—is a widely overlooked opportunity. Off-label prescribing (ie, for a nonapproved indication) is legal in most countries and tends to shift the burden of liability and cost to physicians and pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogosnitzky, Moshe, Berkowitz, Esther, Jadad, Alejandro R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224168/
https://www.ncbi.nlm.nih.gov/pubmed/32374264
http://dx.doi.org/10.2196/19199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224168/
https://www.ncbi.nlm.nih.gov/pubmed/32374264
http://dx.doi.org/10.2196/19199

Ejemplares similares